Search Results

Reduced risk of infection after change in regimen for abortion

Source: Reactions, Volume 1, Number 1261, 2009-07-18 , pp. 1-1(1)

Publisher: Adis International

Warfarin: Fetal subdural haematoma following in utero exposure: case report

Source: Reactions, Volume 1, Number 1244, 2009-03-21 , pp. 45-45(1)

Publisher: Adis International

Rapid uptake of mifepristone following US FDA approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 571, 2009-02-07 , pp. 3-3(1)

Publisher: Adis International

Misoprostol: Uterine perforation and haemorrhage during second trimester surgical abortion: 4 case reports

Source: Reactions, Volume 1, Number 1222, 2008-10-04 , pp. 24-25(2)

Publisher: Adis International

Misoprostol for second-trimester abortion induction

Source: Inpharma, Volume 1, Number 1624, 2008-02-09 , pp. 19-19(1)

Publisher: Adis International

Misoprostol for incomplete abortion in developing countries

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 17-17(1)

Publisher: Adis International

Medical and surgical abortion deliver similar subsequent risk

Source: Inpharma, Volume 1, Number 1602, 2007-08-25 , pp. 10-10(1)

Publisher: Adis International

Sublingual misoprostol compared with vaginal misoprostol for medical abortion

Source: Inpharma, Volume 1, Number 1592, 2007-06-16 , pp. 1-1(1)

Publisher: Adis International

Abortion strategies with mifepristone + misoprostol

Source: Inpharma, Volume 1, Number 1586, 2007-05-05 , pp. 14-14(1)

Publisher: Adis International

Mifepristone followed by misoprostol shows potential in the treatment of early pregnancy failure

Source: Inpharma, Volume 1, Number 1573, 2007-02-03 , pp. 14-14(1)

Publisher: Adis International

IV fentanyl + midazolam superior for reducing intraop pain

Source: Inpharma, Volume 1, Number 1566, 2006-12-02 , pp. 16-16(1)

Publisher: Adis International

Vaginal misoprostol appears to be effective and well-tolerated for abortion of second-trimester pregnancy in women with one prior Caesarean section

Source: Inpharma, Volume 1, Number 1564, 2006-11-18 , pp. 12-12(1)

Publisher: Adis International

D&E alternative to induction for second-trimester terminations

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 504, 2006-06-03 , pp. 7-7(1)

Publisher: Adis International

Very low-dose oral mifepristone immediately followed by intravaginal misoprostol effectively and rapidly induces abortion

Source: Inpharma, Volume 1, Number 1541, 2006-06-10 , pp. 11-11(1)

Publisher: Adis International

Of the two most recent deaths reported to the US FDA after mifepristone [Mifeprex] and misoprostol use, one was unrelated to the drugs

Source: Reactions, Volume 1, Number 1100, 2006-05-06 , pp. 2-2(1)

Publisher: Adis International

Mifeprex: two additional sepsis deaths reported to US FDA

Source: Reactions, Volume 1, Number 1094, 2006-03-25 , pp. 2-2(1)

Publisher: Adis International

Mifepristone/misoprostol: Fatal septic shock: case report

Source: Reactions, Volume 1, Number 1089, 2006-02-18 , pp. 20-20(1)

Publisher: Adis International

Fatal sepsis with mifepristone, but no need to abort the drug

Source: Reactions, Volume 1, Number 1081, 2005-12-10 , pp. 2-2(1)

Publisher: Adis International

Mifepristone/misoprostol: Fatal septic shock associated with Clostridium sordellii: 4 case reports

Source: Reactions, Volume 1, Number 1081, 2005-12-10 , pp. 19-19(1)

Publisher: Adis International

Fatal sepsis with mifepristone, but no need to abort the drug

Source: Inpharma, Volume 1, Number 1517, 2005-12-10 , pp. 3-3(1)

Publisher: Adis International